Volume 30, Number 7—July 2024
Dispatch
Effect of Rodent Control Program on Incidence of Zoonotic Cutaneous Leishmaniasis, Iran
Abstract
We report the effect of a rodent control program on the incidence of zoonotic cutaneous leishmaniasis in an endemic region of Iran. A 1-year interruption in rodent control led to 2 years of increased incidence of zoonotic cutaneous leishmaniasis. Restarting rodent control led to a decline of zoonotic cutaneous leishmaniasis.
Leishmaniasis is a neglected tropical disease that is prevalent worldwide (1). Cutaneous leishmaniasis (CL) is endemic in different regions of Iran and has an approximate incidence rate of 1.18 cases/100,000 population and a difference of 5.7 disability-adjusted life-years (2). Zoonotic cutaneous leishmaniasis (ZCL), caused by the parasite Leishmania major, is the primary cause of CL in Iran, where anthroponotic cutaneous leishmaniasis, caused by Leishmania tropica, is less prevalent (2,3). Because rodents are the main reservoirs of ZCL, the rodent control program (RCP) is an important intervention for the control of ZCL in endemic areas (1). ZCL is endemic in Jahrom county in Fars Province, Iran (Appendix Figure 1). We report the effects of an RCP on incidence of ZCL in this region. This study was approved by the Research and Ethics Committee of Jahrom University of Medical Sciences, Jahrom, Iran (ethics code IR.JUMS.REC.1402.067).
The RCP is conducted in rural areas of Jahrom county 5 times a year, beginning with the destruction of rodent nests in early April (4). Once a month in April, May, June, and September, rodent nest baiting is performed by using a mixture of wheat with 2.5% zinc phosphide (4) (Appendix Figure 3). The rodent nest baiting is conducted in a 500-m circle around houses within the intervention area (4).
The RCP was completely ceased during the first year of the COVID-19 pandemic in Jahrom county because of a lack of equipment and personnel. The program was resumed routinely in early April 2021 (5). The outcome of the 1-year interruption in the RCP was a mild increase in the incidence of ZCL in 2020 and a high increase in ZCL in 2021 (Appendix Figure 2). Incidence rates for the period before the pandemic were stable: 103.7 cases/100,000 population in 2016, 95.1 cases/100,000 population in 2017, 99.7 cases/100,000 population in 2018, and 99.6 cases/100,000 population in 2019 (Figure). After the RCP stopped because of the COVID-19 pandemic, ZCL incidence rates increased to 129.4 cases/100,000 population in 2020 and 321.5 cases/100,000 population in 2021, (Table; Figure). Of interest, the outcome of restarting the RCP in 2021 was not apparent until 2022 and 2023, when the incidence rate of ZCL decreased to 72.1 cases/100,000 population in 2022 and 19.2 cases/100,000 population in 2023 (Table; Figure; Appendix Figure 2).
Jahrom county has an agricultural environment that provides suitable conditions for both the rodent reservoirs and sand fly vectors of L. major. Although different studies have demonstrated the effectiveness of the RCP for control of ZCL (4,6,7), little is known about the impact of a short-term interruption of the RCP on the incidence of ZCL in an endemic region. The unplanned interruption of the RCP in Jahrom county because of the COVID-19 pandemic gave us the opportunity to evaluate the impact of the RCP on the incidence of ZCL in an endemic area. Although the RCP was paused for only 1 year and resumed routinely in early April 2021, a slight increase in the incidence of ZCL was observed (129.4 cases/100,000 population in 2020) and a marked increase in ZCL the following year (321.5 cases/100,000 population in 2021). However, because of the COVID-19 lockdown, the diagnosis and treatment of CL patients were interrupted during the first year of the pandemic (2020), so those factors could be involved in the increase in the incidence of ZCL in 2020 and 2021. Of interest, a sharp decline in the incidence rates was observed in 2022 and 2023 (72.1 cases/100,000 population in 2022 and 19.2 cases/100,000 population in 2023). However, comparing the incidences of ZCL in 2022 and 2023 with the incidences before 2020 has shown that factors other than the RCP could be contributing to the decline of ZCL because the incidence rates of 2022 and 2023 were much lower than the incidence rates before 2020 (Table; Figure; Appendix Figure 2). Other factors, such as climate conditions and rainfall, which are involved in the propagations of rodents and sand flies, could also contribute to the decline of ZCL observed in 2022 and 2023.
The emergence of COVID-19 has a considerable influence on the burden of noncommunicable and communicable diseases throughout the world and in Iran (8,9). In Brazil, the COVID-19 pandemic seems to have contributed to an increase in the incidence of tegumentary leishmaniasis in 2020 (10). A decreasing incidence of CL was reported in an endemic region in western Iran during the COVID-19 pandemic (2020–2021), possibly because of the disruption of CL diagnosis and treatment follow-up (11).
Our study showed a 1-year interruption to the RCP contributed to 2 years of increased incidence of ZCL in an endemic region of Iran. Restarting the RCP led to the decline of ZCL after 2 years of program activity. However, additional factors, such as environmental conditions (e.g., climate conditions and rainfall) that have an influence on vector and reservoir propagation, and diagnosis and treatment follow-up, could influence the incidence of ZCL (12, 13). In the absence of a vaccine for ZCL, an RCP is an effective strategy for ZCL control in endemic regions.
Dr. Abdoli is associate professor of medical parasitology at Jahrom University of Medical Sciences. His research interests include parasitology and zoonotic infections.
Acknowledgment
This study was supported by Jahrom University of Medical Sciences, Jahrom, Iran (grant nos. 402000084 and 99000159) and the National Institute for Medical Research Development (grant no. 978507).
References
- Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7:581–96. DOIPubMedGoogle Scholar
- Piroozi B, Moradi G, Alinia C, Mohamadi P, Gouya MM, Nabavi M, et al. Incidence, burden, and trend of cutaneous leishmaniasis over four decades in Iran. Iran J Public Health. 2019;48(Supple 1):28–35.
- Mazaherifar S, Solhjoo K, Rasti S, Heidarnejadi SM, Abdoli A. Patterns of cutaneous leishmaniasis during the COVID-19 pandemic in four endemic regions of Iran. Trans R Soc Trop Med Hyg. 2023;117:38–44. DOIPubMedGoogle Scholar
- Ershadi MR, Zahraei-Ramazani A-R, Akhavan A-A, Jalali-Zand A-R, Abdoli H, Nadim A. Rodent control operations against zoonotic cutaneous leishmaniasis in rural Iran. Ann Saudi Med. 2005;25:309–12. DOIPubMedGoogle Scholar
- Mazaherifar S, Solhjoo K, Abdoli A. Outbreak of cutaneous leishmaniasis before and during the COVID-19 pandemic in Jahrom, an endemic region in the southwest of Iran. Emerg Microbes Infect. 2022;11:2218–21. DOIPubMedGoogle Scholar
- Rezaei F, Saghafipour A, Rassi Y, Abai MR. Effect of rodents’ management plan on controlling cutaneous leishmaniasis in endemic centers of Gom province in 2012. Hormozgan Med J. 2015;19:219–25.
- Kalteh EA, Sofizadeh A, Yapng Gharavi AH, Ozbaki GM, Kamalinia HR, Bagheri A, et al. Effect of wild rodents control in reduction of zoonotic cutaneous leishmaniasis in Golestan province, north of Iran (2016). Majallah-i Danishgah-i Ulum-i Pizishki-i Gurgan. 2019;21:94–100.
- Lim MA, Huang I, Yonas E, Vania R, Pranata R. A wave of non-communicable diseases following the COVID-19 pandemic. Diabetes Metab Syndr. 2020;14:979–80. DOIPubMedGoogle Scholar
- Abdoli A, Falahi S, Kenarkoohi A. COVID-19-associated opportunistic infections: a snapshot on the current reports. Clin Exp Med. 2022;22:327–46. DOIPubMedGoogle Scholar
- Andrade MC, Ferreti Bonan PR, Hilan E, Marques NP, Guimarães-Carvalho SF, Martelli H. COVID-19 pandemic causes increased clinic visits with diagnosis of tegumentary leishmaniasis in Brazil in 2020. Int J Infect Dis. 2021;113:87–9. DOIPubMedGoogle Scholar
- Shams M, Rashidi A, Mohamadi J, Moradi M, Pakzad R, Naserifar R, et al. Real-time impact of COVID-19 pandemic on cutaneous leishmaniasis case finding and strategic planning, preventive interventions, control and epidemiology in a region with a high burden of cutaneous leishmaniasis and COVID-19: A cross-sectional descriptive study based on registry data in Ilam-Iran. Health Sci Rep. 2023;6:
e1489 . DOIPubMedGoogle Scholar - Abdolahnejad A, Mousavi SH, Sofizadeh A, Jafari N, Shiravand B. Climate change and distribution of zoonotic cutaneous leishmaniasis (ZCL) reservoir and vector species in central Iran. Model Earth Syst Environ. 2021;7:105–15. DOIGoogle Scholar
- Charrahy Z, Yaghoobi-Ershadi MR, Shirzadi MR, Akhavan AA, Rassi Y, Hosseini SZ, et al. Climate change and its effect on the vulnerability to zoonotic cutaneous leishmaniasis in Iran. Transbound Emerg Dis. 2022;69:1506–20. DOIPubMedGoogle Scholar
Figure
Table
Cite This ArticleTable of Contents – Volume 30, Number 7—July 2024
EID Search Options |
---|
Advanced Article Search – Search articles by author and/or keyword. |
Articles by Country Search – Search articles by the topic country. |
Article Type Search – Search articles by article type and issue. |
Please use the form below to submit correspondence to the authors or contact them at the following address:
Amir Abdoli, Jahrom University of Medical Sciences, PO Box 74148-46199, Ostad Motahari Ave, Jahrom, Iran
Top